Cardiovascular diseases (CVD) are a significant cause of human health harm. In the past,
stem cell therapy was reported to have functional defects, such as immune rejection …

Since the initial release of miRPathDB, tremendous progress has been made in the field of
microRNA (miRNA) research. New miRNA reference databases have emerged, a vast …

Human adipose tissue-derived stem/stromal cells (hASCs) are adult multipotent
mesenchymal stem/stromal cells with immunomodulatory capacities. Here, we present up-to …

The main strategy of tissue repair and regeneration focuses on the application of
mesenchymal stem cells and cell-based nanoparticles, but there are still multiple challenges …

Intra-articular administration of adipose-derived mesenchymal stem cells (ASCs), either in
vitro expanded or within adipose tissue-based products obtained at point-of-care, has …

Osteoarthritis (OA) is a degenerative joint condition that contributes to years lived with
disability. Current therapeutic approaches are limited as there are no disease-modifying …

“Extracellular vesicles”(EVs) is a term gathering biological particles released from cells that
act as messengers for cell-to-cell communication. Like cells, EVs have a membrane with a …

Mesenchymal stromal cells (MSCs) have been utilized in cell therapy for various diseases.
Recent studies have demonstrated that extracellular vesicles (EVs) released by MSCs play …

Acute kidney injury (AKI) is a common and potential life-threatening disease in patients
admitted to hospital, affecting 10%–15% of all hospitalizations and around 50% of patients …

Among the available therapeutics for the conservative treatment of osteoarthritis (OA),
mesenchymal stromal cells (MSCs)-based products appear to be the most promising …